<DOC>
	<DOC>NCT01331434</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fed conditions.</brief_summary>
	<brief_title>Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Exemestane</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to exemestane or any comparable or similar product.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>